Geographical influences on the chemical composition and antifungal activity of Xylopia aromatica (Lam.) Mart. leaf essential oil

The study assessed the chemical composition and antifungal activity of Xylopia aromatica (Lam.) Mart. leaf essential oil, which was gathered in four different locations in Sao Paulo, Brazil, on Candida species and, for the first time, on Cryptococcus spp. To find appropriate fungal cell enzymes for the bulk of phytoligands, molecular docking simulations were run. The output and percentage of essential oil components assessed in the same and different locations varied. Rio Bonito - RB1 essential oils are mostly composed of beta-phellan-drene, alpha and beta-pinene and bicyclogermacrene. RB2, on the other hand, exhibited bicyclogermacrene, spathu-lenol, and undetermined 3, as well as variance in biological activity. At a dosage of 125 mu g mL(-1), RB1 displayed antifungal activity against the Candida krusei strain, while at a dose of 500 mu g mL(-1), RB1 and RB2 demonstrated antifungal activity against Cryptococcus neoformans and C. gattii isolates. Given the established resistance to fluconazole, the alpha and beta-pinene standards demonstrated in vitro activity against C. krusei (MIC=16 mu g mL(-1)), indicating the need for further research in this area. In silico investigations identified the enzymes sterol-14-alpha-demethylase and N-myristoyltransferase as potential pinenes enzymatic targets. The environment altered the biological effect of X. aromatica essential oil, implying an interaction between the components. (c) 2023 Published by Elsevier B.V. on behalf of SAAB.

Automated summary

The study evaluated the chemical composition and antifungal activity of Xylopia aromatica leaf essential oil from different locations in Sao Paulo, Brazil. It also identified potential enzymatic targets for the oil's phytoligands through molecular docking simulations. The essential oil components and their percentage varied among the different locations. The essential oil exhibited antifungal activity against Candida and Cryptococcus isolates, with certain components showing in vitro activity against resistant strains.